Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-10

Clinical Trial Update: Dexmedetomidine Premedication in Hypertensive Patients [Phase 3]

View source ↗

Summary

Dexmedetomidine was studied as a premedication in hypertensive patients in a Phase 3 trial which has completed. The update notes the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Duzce University | Conditions: Hypertension | Phase 3 | Status: COMPLETED